These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

354 related items for PubMed ID: 28619071

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Comparative assessment of An. gambiae and An. stephensi mosquitoes to determine transmission-reducing activity of antibodies against P. falciparum sexual stage antigens.
    Eldering M, Bompard A, Miura K, Stone W, Morlais I, Cohuet A, van Gemert GJ, Brock PM, Rijpma SR, van de Vegte-Bolmer M, Graumans W, Siebelink-Stoter R, Da DF, Long CA, Morin MJ, Sauerwein RW, Churcher TS, Bousema T.
    Parasit Vectors; 2017 Oct 17; 10(1):489. PubMed ID: 29041962
    [Abstract] [Full Text] [Related]

  • 43. Anti-Pfs25 human plasma reduces transmission of Plasmodium falciparum isolates that have diverse genetic backgrounds.
    Da DF, Dixit S, Sattabonkot J, Mu J, Abate L, Ramineni B, Ouedraogo JB, MacDonald NJ, Fay MP, Su XZ, Cohuet A, Wu Y.
    Infect Immun; 2013 Jun 17; 81(6):1984-9. PubMed ID: 23509152
    [Abstract] [Full Text] [Related]

  • 44. Identification of domains within Pfs230 that elicit transmission blocking antibody responses.
    Tachibana M, Miura K, Takashima E, Morita M, Nagaoka H, Zhou L, Long CA, Richter King C, Torii M, Tsuboi T, Ishino T.
    Vaccine; 2019 Mar 22; 37(13):1799-1806. PubMed ID: 30824357
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Global diversity of the gene encoding the Pfs25 protein-a Plasmodium falciparum transmission-blocking vaccine candidate.
    Sookpongthai P, Utayopas K, Sitthiyotha T, Pengsakul T, Kaewthamasorn M, Wangkanont K, Harnyuttanakorn P, Chunsrivirot S, Pattaradilokrat S.
    Parasit Vectors; 2021 Nov 08; 14(1):571. PubMed ID: 34749796
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. IgG2 antibodies against a clinical grade Plasmodium falciparum CSP vaccine antigen associate with protection against transgenic sporozoite challenge in mice.
    Schwenk R, DeBot M, Porter M, Nikki J, Rein L, Spaccapelo R, Crisanti A, Wightman PD, Ockenhouse CF, Dutta S.
    PLoS One; 2014 Nov 08; 9(10):e111020. PubMed ID: 25343487
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51.
    Wu Y, Ellis RD, Shaffer D, Fontes E, Malkin EM, Mahanty S, Fay MP, Narum D, Rausch K, Miles AP, Aebig J, Orcutt A, Muratova O, Song G, Lambert L, Zhu D, Miura K, Long C, Saul A, Miller LH, Durbin AP.
    PLoS One; 2008 Jul 09; 3(7):e2636. PubMed ID: 18612426
    [Abstract] [Full Text] [Related]

  • 51. Saccharomyces cerevisiae recombinant Pfs25 adsorbed to alum elicits antibodies that block transmission of Plasmodium falciparum.
    Kaslow DC, Bathurst IC, Lensen T, Ponnudurai T, Barr PJ, Keister DB.
    Infect Immun; 1994 Dec 09; 62(12):5576-80. PubMed ID: 7960139
    [Abstract] [Full Text] [Related]

  • 52. Novel adenovirus encoded virus-like particles displaying the placental malaria associated VAR2CSA antigen.
    Andersson AC, Resende M, Salanti A, Nielsen MA, Holst PJ.
    Vaccine; 2017 Feb 22; 35(8):1140-1147. PubMed ID: 28131394
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Immunization of mice with DNA-based Pfs25 elicits potent malaria transmission-blocking antibodies.
    Lobo CA, Dhar R, Kumar N.
    Infect Immun; 1999 Apr 22; 67(4):1688-93. PubMed ID: 10085005
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. A Viral-Vectored Multi-Stage Malaria Vaccine Regimen With Protective and Transmission-Blocking Efficacies.
    Yusuf Y, Yoshii T, Iyori M, Mizukami H, Fukumoto S, Yamamoto DS, Emran TB, Amelia F, Islam A, Syafira I, Yoshida S.
    Front Immunol; 2019 Apr 22; 10():2412. PubMed ID: 31681301
    [Abstract] [Full Text] [Related]

  • 58. Structure and mechanism of a transmission blocking vaccine candidate protein Pfs25 from P. falciparum: a molecular modeling and docking study.
    Sharma B.
    In Silico Biol; 2008 Apr 22; 8(3-4):193-206. PubMed ID: 19032156
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Conjugating recombinant proteins to Pseudomonas aeruginosa ExoProtein A: a strategy for enhancing immunogenicity of malaria vaccine candidates.
    Qian F, Wu Y, Muratova O, Zhou H, Dobrescu G, Duggan P, Lynn L, Song G, Zhang Y, Reiter K, MacDonald N, Narum DL, Long CA, Miller LH, Saul A, Mullen GE.
    Vaccine; 2007 May 16; 25(20):3923-33. PubMed ID: 17428587
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.